Literature DB >> 6704265

Systemic lupus erythematosus presenting with cardiac tamponade.

N Carroll, J A Barrett.   

Abstract

A previously well 36 year old man presented with cardiac tamponade as the initial manifestation of systemic lupus erythematosus. This diagnosis should, therefore, be considered not only in cases of pericarditis but also in those of tamponade.

Entities:  

Mesh：

Year:  1984        PMID： 6704265      PMCID： PMC481529          DOI： 10.1136/hrt.51.4.452

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


  6 in total

1.  The heart in systemic lupus erythematosus.

Authors:  M A SHEARN
Journal:  Am Heart J       Date:  1959-09       Impact factor: 4.749

2.  Pericardial tamponade in systemic lupus erythematosus; with absent hemolytic complement activity in pericardial fluid.

Authors:  D L Goldenberg; G Leff; A I Grayzel
Journal:  N Y State J Med       Date:  1975-05

3.  Pericardial tamponade: a major presenting manifestation of hydralazine-induced lupus syndrome.

Authors:  R M Carey; M Coleman; A Feder
Journal:  Am J Med       Date:  1973-01       Impact factor: 4.965

4.  Cardiac tamponade as an initial finding in systemic lupus erythematosus.

Authors:  R J Lerer
Journal:  Am J Dis Child       Date:  1972-09

5.  Pericardiocentesis.

Authors:  J G Krikorian; E W Hancock
Journal:  Am J Med       Date:  1978-11       Impact factor: 4.965

6.  Pericardial tamponade. A presenting manifestation of procainamide-induced lupus erythematosus.

Authors:  M K Ghose
Journal:  Am J Med       Date:  1975-04       Impact factor: 4.965
  6 in total
  2 in total

1.  Betaxolol and drug-induced lupus complicated by pericarditis and large pericardial effusion.

Authors:  J T Hardee; C A Roldan; T W Du Clos
Journal:  West J Med       Date:  1997-08

Review 2.  Calcified constrictive pericarditis resulting in tamponade in a patient with systemic lupus erythematosus.

Authors:  Antigone Pieta; Eleftherios Pelechas; Nafsika Gerolymatou; Paraskevi V Voulgari; Alexandros A Drosos
Journal:  Rheumatol Int       Date:  2020-11-18       Impact factor: 2.631
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.